Potentiation and priming of platelet activation: a potential target for antiplatelet therapy

Area of Science:

• Cardiovascular Medicine
• Hematology
• Pharmacology

Background:

• Ischemic cardiovascular events are a leading global cause of death.
• Platelet aggregation and thrombus formation are key in acute arterial ischemic events.
• Current antiplatelet therapies have suboptimal efficacy, necessitating new targets.

Purpose of the Study:

• To review molecules that amplify platelet aggregation (potentiators and primers).
• To discuss the potential of these molecules as novel pharmacologic targets for antiplatelet therapy.
• To explore the pharmacologic modulation of these molecules for antithrombotic purposes.

Main Methods:

• Literature review of existing research on platelet potentiating and priming molecules.
• Analysis of the role of these molecules in pathological thrombus formation versus primary hemostasis.
• Discussion of potential therapeutic strategies targeting these molecules.

Main Results:

• Several molecules act as potentiators or primers, significantly amplifying platelet aggregation.
• These molecules play a crucial role in pathological thrombus formation.
• They are less involved in primary hemostasis, suggesting a favorable therapeutic window.

Conclusions:

• Molecules amplifying platelet aggregation are attractive novel targets for antiplatelet therapy.
• Targeting these potentiators and primers could lead to more effective antithrombotic treatments.
• Pharmacologic modulation of these pathways holds promise for managing ischemic cardiovascular disorders.